These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 25111771

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Prognosis after acute coronary syndrome. Lack of difference according to the sex].
    Bounhoure JP, Farah B, Fajadet J, Marco J.
    Bull Acad Natl Med; 2004; 188(3):383-97; discussion 397-9. PubMed ID: 15584651
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Early readmissions after percutaneous coronary intervention in a rural tertiary care center (from the Guthrie Health Off-label Stent [GHOST] Registry).
    Harjai KJ, Singh M, Boura J.
    Am J Cardiol; 2012 Aug 15; 110(4):491-7. PubMed ID: 22579345
    [Abstract] [Full Text] [Related]

  • 6. Predictors and etiologies of 30-day readmissions in patients with non-ST-elevation acute coronary syndrome.
    Lemor A, Hernandez GA, Patel N, Blumer V, Sud K, Cohen MG, De Marchena E, Kini AS, Sharma SK, Alfonso CE.
    Catheter Cardiovasc Interv; 2019 Feb 15; 93(3):373-379. PubMed ID: 30280472
    [Abstract] [Full Text] [Related]

  • 7. Readmission in the 30 days after percutaneous coronary intervention.
    Yost GW, Puher SL, Graham J, Scott TD, Skelding KA, Berger PB, Blankenship JC.
    JACC Cardiovasc Interv; 2013 Mar 15; 6(3):237-44. PubMed ID: 23517834
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Prognostic value of plasma brain natriuretic peptide and C-reactive protein in patients with acute coronary syndromes underwent percutaneous coronary intervention].
    He B, Ding S, Pu J, Liu JP, Song W, Du YP, Shen JY, Jin SX, Sun Y, Shen L.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr 15; 34(4):349-52. PubMed ID: 16776932
    [Abstract] [Full Text] [Related]

  • 13. Effects of upstream tirofiban versus downstream tirofiban on myocardial damage and 180-day clinical outcomes in high-risk acute coronary syndromes patients undergoing percutaneous coronary interventions.
    Liu T, Xie Y, Zhou YJ, Li YP, Ma HY, Guo YH, Liu YY, Zhao YX, Shi DM.
    Chin Med J (Engl); 2009 Aug 05; 122(15):1732-7. PubMed ID: 19781316
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Ischemic outcomes after coronary intervention of calcified vessels in acute coronary syndromes. Pooled analysis from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) and ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) TRIALS.
    Généreux P, Madhavan MV, Mintz GS, Maehara A, Palmerini T, Lasalle L, Xu K, McAndrew T, Kirtane A, Lansky AJ, Brener SJ, Mehran R, Stone GW.
    J Am Coll Cardiol; 2014 May 13; 63(18):1845-54. PubMed ID: 24561145
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of clopidogrel reloading in patients with acute coronary syndrome undergoing percutaneous coronary intervention during chronic clopidogrel therapy (from the Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty [ARMYDA-8 RELOAD-ACS] trial).
    Patti G, Pasceri V, Mangiacapra F, Colonna G, Vizzi V, Ricottini E, Montinaro A, D'Ambrosio A, Wijns W, Barbato E, Di Sciascio G, ARMYDA-8 RELOAD-ACS Investigators.
    Am J Cardiol; 2013 Jul 15; 112(2):162-8. PubMed ID: 23601577
    [Abstract] [Full Text] [Related]

  • 18. Effects of moderate-to-severe obstructive sleep apnea on the clinical manifestations of plaque vulnerability and the progression of coronary atherosclerosis in patients with acute coronary syndrome.
    Nakashima H, Kurobe M, Minami K, Furudono S, Uchida Y, Amenomori K, Nunohiro T, Takeshita S, Maemura K.
    Eur Heart J Acute Cardiovasc Care; 2015 Feb 15; 4(1):75-84. PubMed ID: 24855286
    [Abstract] [Full Text] [Related]

  • 19. Impact of nonculprit vessel myocardial perfusion on outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes: analysis from the ACUITY trial (Acute Catheterization and Urgent Intervention Triage Strategy).
    Lansky AJ, Ng VG, Meller S, Xu K, Fahy M, Feit F, Ohman EM, White HD, Mehran R, Bertrand ME, Desmet W, Hamon M, Stone GW.
    JACC Cardiovasc Interv; 2014 Mar 15; 7(3):266-75. PubMed ID: 24650400
    [Abstract] [Full Text] [Related]

  • 20. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
    Bruder O, Breuckmann F, Jensen C, Jochims M, Naber CK, Barkhausen J, Erbel R, Sabin GV, Herzinfarktverbund Essen.
    Herz; 2008 Mar 15; 33(2):136-42. PubMed ID: 18344033
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.